Lee I-Neng, Chen Chien-Hung, Sheu Jin-Chuan, Lee Hsuan-Shu, Huang Guan-Tarn, Yu Chen-Yin, Lu Fung-Jou, Chow Lu-Ping
Graduate Institute of Biochemistry and Molecular Biology, College of Medicine, National Taiwan University, Taipei, Taiwan.
J Proteome Res. 2005 Nov-Dec;4(6):2062-9. doi: 10.1021/pr0502018.
Hepatocellular carcinoma (HCC) is one of the leading causes of cancer-related death throughout the world. Although hepatitis B or C viral infections are main risk factors for HCC, the molecular mechanisms leading to HCC formation have not been clarified. To reduce the mortality and improve the effectiveness of therapy, it is important to search for changes in tumor-specific biomarkers whose function may involve in disease progression and which may be useful as potential therapeutic targets. In this study, we employed two-dimensional difference gel electrophoresis (2D-DIGE) combined with nano flow liquid chromatography tandem mass spectrometry (nanoLC-MS/MS) to investigate differentially expressed proteins in HCC. For each of eight HCC patients, Cy3-labeled proteins isolated from tumor tissue were combined with Cy5-labeled proteins isolated from the surrounding nontumor tissue and separated by 2D gel electrophoresis along with a Cy2-labeled mixture of all tumor and nontumor samples as an internal standard. Thirty-four protein spots corresponding to 30 different proteins were identified by nanoLC-MS/MS as showing significant change (paired t-test, p < 0.05) in the level of expression between tumor and nontumor tissues. Sixteen proteins were up-regulated and 14 were down-regulated in HCC; they seem to play important roles in a variety of pathways including glycolysis, fatty acid transport and trafficking, amino acid metabolism, iron and xenobiotic metabolism, ethanol metabolism, cell cycle regulation, cytoskeleton, and stress. A remarkable finding is the up-regulation of 14-3-3gamma protein in HCC. 14-3-3 isoforms had been linked to carcinogenesis because they are involved in various cellular processes such as cell cycle regulation, apoptosis, proliferation, and differentiation. In conclusion, 2D-DIGE is an efficient strategy that enables us to identify differentially expressed proteins in HCC. Identification of potential biomarkers, such as the pinpointing of 14-3-3gamma in our findings, may provide further useful insights into the pathogenesis of HCC.
肝细胞癌(HCC)是全球癌症相关死亡的主要原因之一。虽然乙型或丙型肝炎病毒感染是HCC的主要危险因素,但导致HCC形成的分子机制尚未阐明。为了降低死亡率并提高治疗效果,寻找肿瘤特异性生物标志物的变化非常重要,这些生物标志物的功能可能与疾病进展有关,并且可能作为潜在的治疗靶点。在本研究中,我们采用二维差异凝胶电泳(2D-DIGE)结合纳流液相色谱串联质谱(nanoLC-MS/MS)来研究HCC中差异表达的蛋白质。对于8例HCC患者中的每一例,从肿瘤组织中分离的Cy3标记蛋白质与从周围非肿瘤组织中分离的Cy5标记蛋白质相结合,并与作为内标的所有肿瘤和非肿瘤样品的Cy2标记混合物一起通过二维凝胶电泳分离。通过nanoLC-MS/MS鉴定出34个对应于30种不同蛋白质的蛋白点,显示肿瘤组织和非肿瘤组织之间的表达水平有显著变化(配对t检验,p < 0.05)。在HCC中,16种蛋白质上调,14种蛋白质下调;它们似乎在包括糖酵解、脂肪酸转运和运输、氨基酸代谢、铁和外源性物质代谢、乙醇代谢、细胞周期调节、细胞骨架和应激等多种途径中发挥重要作用。一个显著的发现是HCC中14-3-3γ蛋白的上调。14-3-3异构体与致癌作用有关,因为它们参与细胞周期调节、凋亡、增殖和分化等各种细胞过程。总之,2D-DIGE是一种有效的策略,使我们能够鉴定HCC中差异表达的蛋白质。鉴定潜在的生物标志物,如我们发现中确定的14-3-3γ,可能为HCC的发病机制提供进一步有用的见解。